Literature DB >> 26540556

The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis.

P Ruscitti1, F Ciccia2, P Cipriani1, G Guggino2, P Di Benedetto1, A Rizzo3, V Liakouli1, O Berardicurti1, F Carubbi1, G Triolo2, R Giacomelli1.   

Abstract

In this work, we aimed to evaluate the levels of ferritin enriched in H subunits (H-ferritin) and ferritin enriched in L subunits (L-ferritin) and the cells expressing these two molecules in the lymph node (LN) biopsies obtained from adult-onset Still's disease (AOSD) patients, and the possible correlation among these data and the severity of the disease. Ten patients with AOSD underwent LN biopsy. All the samples were stained by immunofluorescence. A statistical analysis was performed to estimate the possible correlation among both H-ferritin and L-ferritin tissue expression and the clinical picture of the disease. Furthermore, the same analysis was performed to evaluate the possible correlation among the number of CD68(+)/H-ferritin(+) or CD68(+)/L-ferritin(+) cells and the clinical picture. Immunofluorescence analysis demonstrated an increased tissue H-ferritin expression in the LNs of AOSD patients. This increased expression correlated with the severity of the disease. An increased number of CD68 macrophages expressing H-ferritin was observed in the LN samples of our patients. Furthermore, we observed that the number of CD68(+)/H-ferritin(+) cells correlated significantly with the severity of the clinical picture. Our data showed an imbalance between the levels of H- and L-ferritin in LNs of AOSD patients and the evidence of an increased number of CD68(+)/H-ferritin(+) cells in the same organs. Furthermore, a correlation among both the tissue H-ferritin levels and the CD68(+)/H-ferritin(+) cells and the clinical picture was observed.
© 2015 British Society for Immunology.

Entities:  

Keywords:  H-ferritin; adult-onset Still's disease; hyperferritinaemic syndrome; macrophage

Mesh:

Substances:

Year:  2015        PMID: 26540556      PMCID: PMC4750598          DOI: 10.1111/cei.12738

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  51 in total

Review 1.  Regulation of ferritin genes and protein.

Authors:  Frank M Torti; Suzy V Torti
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

2.  Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool.

Authors:  D J Piñero; J Hu; B M Cook; R C Scaduto; J R Connor
Journal:  Biochim Biophys Acta       Date:  2000-09-20

3.  Clinical features and prognosis in 82 patients with adult-onset Still's disease.

Authors:  You Jae Kim; Bon San Koo; Yong-Gil Kim; Chang-Keun Lee; Bin Yoo
Journal:  Clin Exp Rheumatol       Date:  2013-09-18       Impact factor: 4.473

4.  Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.

Authors:  H E Broxmeyer; J Bognacki; M H Dorner; M de Sousa
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

5.  Adult Still's disease: manifestations, disease course, and outcome in 62 patients.

Authors:  J Pouchot; J S Sampalis; F Beaudet; S Carette; F Décary; M Salusinsky-Sternbach; R O Hill; A Gutkowski; M Harth; D Myhal
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

6.  Interleukin 1 induces ferritin heavy chain in human muscle cells.

Authors:  Y Wei; S C Miller; Y Tsuji; S V Torti; F M Torti
Journal:  Biochem Biophys Res Commun       Date:  1990-05-31       Impact factor: 3.575

7.  Effects of isoferritins on human granulocytes.

Authors:  H W Hann; M W Stahlhut; S Lee; W T London; R S Hann
Journal:  Cancer       Date:  1989-06-15       Impact factor: 6.860

Review 8.  The TIM gene family: emerging roles in immunity and disease.

Authors:  Vijay K Kuchroo; Dale T Umetsu; Rosemarie H DeKruyff; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

9.  Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy.

Authors:  Y K Jeon; J H Paik; S-S Park; S O Park; Y A Kim; J E Kim; Y W Song; C W Kim
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

10.  Adult-onset Still's disease. Clinical course and outcome.

Authors:  J J Cush; T A Medsger; W C Christy; D C Herbert; L A Cooperstein
Journal:  Arthritis Rheum       Date:  1987-02
View more
  12 in total

1.  Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.

Authors:  Piero Ruscitti; Carmela Rago; Luciana Breda; Paola Cipriani; Vasiliki Liakouli; Onorina Berardicurti; Francesco Carubbi; Caterina Di Battista; Alberto Verrotti; Roberto Giacomelli
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

2.  Macrophage activation syndrome in systemic lupus erythematosus and systemic-onset juvenile idiopathic arthritis: a retrospective study of similarities and dissimilarities.

Authors:  R Naveen; Avinash Jain; Hafis Muhammed; Latika Gupta; Durga P Misra; Able Lawrence; Vikas Agarwal; Ramnath Misra; Amita Aggarwal
Journal:  Rheumatol Int       Date:  2021-01-02       Impact factor: 2.631

3.  The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.

Authors:  Piero Ruscitti; Onorina Berardicurti; Ilenia Di Cola; Claudia Di Muzio; Elena Di Nino; Roberto Giacomelli; Paola Cipriani
Journal:  Clin Exp Immunol       Date:  2022-05-13       Impact factor: 4.330

4.  The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.

Authors:  Piero Ruscitti; Onorina Berardicurti; Ilenia Di Cola; Claudia Di Muzio; Elena Di Nino; Roberto Giacomelli; Paola Cipriani
Journal:  Clin Exp Immunol       Date:  2022-02-02       Impact factor: 5.732

5.  H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome.

Authors:  P Ruscitti; P Cipriani; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; F Ciccia; G Guggino; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2017-10-20       Impact factor: 4.330

6.  H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease.

Authors:  P Ruscitti; P Cipriani; F Ciccia; P Di Benedetto; V Liakouli; O Berardicurti; F Carubbi; G Guggino; S Di Bartolomeo; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2016-07-28       Impact factor: 4.330

7.  Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers.

Authors:  Piero Ruscitti; Paola Cipriani; Francesco Masedu; Daniela Iacono; Francesco Ciccia; Vasiliki Liakouli; Giuliana Guggino; Francesco Carubbi; Onorina Berardicurti; Paola Di Benedetto; Marco Valenti; Giovanni Triolo; Gabriele Valentini; Roberto Giacomelli
Journal:  BMC Med       Date:  2016-12-01       Impact factor: 8.775

Review 8.  Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review.

Authors:  Meng-Yan Wang; Jin-Chao Jia; Cheng-De Yang; Qiong-Yi Hu
Journal:  Chin Med J (Engl)       Date:  2019-12-05       Impact factor: 2.628

Review 9.  An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.

Authors:  Po-Ku Chen; Der-Yuan Chen
Journal:  J Immunol Res       Date:  2021-06-20       Impact factor: 4.818

10.  Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations.

Authors:  Piero Ruscitti; Paola Di Benedetto; Onorina Berardicurti; Noemi Panzera; Nicolò Grazia; Anna Rita Lizzi; Paola Cipriani; Yehuda Shoenfeld; Roberto Giacomelli
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.